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Renin secretion is regulated by coordinated signaling
between the various cells of the juxtaglomerular apparatus.
The renin-secreting cells (RSC), which play a major role in the
control of blood pressure, are coupled to each other and to
endothelial cells by Connexin40 (Cx40)-containing channels.
In this study, we show that Cx40 knockout (Cx40/) mice,
but not their heterozygous littermates, are hypertensive due
to the increase in the number of RSC, renin biosynthesis, and
plasma renin. Treatment with the angiotensin II receptor AT1
antagonist candesartan or the angiotensin II-converting
enzyme inhibitor ramipril reduced the blood pressure of the
Cx40/ mice to the same levels seen in wild-type (WT)
mice. The elevated blood pressure of the knockout mice was
not affected by clipping one renal artery (2K1C, renin-
dependent model of hypertension) or after a high salt diet.
Under these conditions, however, Cx40/ mice showed an
altered production and release of renin. The renin mRNA
ratio between the clipped and the non-clipped kidney was
lower in the knockout than in the WT 2K1C mice. This
indicates that the response to a change in blood pressure
was altered. The RSC of the Cx40/ mice did not have a
compensatory increase in the levels of either Cx43 or Cx37.
Our data show that renin secretion is dependent on Cx40
and suggest the Cx40/ mice may be a genetic model of
renin-dependent hypertension.
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The control of blood pressure, which is of paramount
importance for the organism, is mostly achieved within the
kidney cortex via the release of renin by the juxtaglomerular
apparatus (JGA).1 Renin is normally secreted in a regulated
manner, as a function of the integration of various
mechanical, osmotic, and electrochemical stimuli, acting on
the different cell types which collectively form the JGA.2 This
regulation implies that JGA cells function in coordination.
One of the mechanisms whereby this coordination may be
achieved is via gap junctions,3–6 the membrane regions where
connexin (Cx) channels for the intercellular sharing of ions
and signaling molecules are localized.7 A functional gap
junction is composed of two opposing hexamers, each
contributed by one of two adjacent cells, and consisting of
an assembly of six connexin proteins.7 Accordingly, gap
junctions made of Cx37, Cx40, and Cx438–10 link the cells of
the JGA.11,12 Furthermore, gap junctions made of Cx40 also
link the endothelial cells of the afferent arteriole to the renin-
secreting cells (RSC), which form the media of the
juxtaglomerular part of this arteriole.8,13
Gap junctional communication via Cx40 channels appears
to play a central role in the function of the vascular
system,13,14 as exemplified by the finding that loss of Cx40
results in chronic hypertension.15–17 While the mechanism of
this effect is still unknown, the observation that changes in
Cx40 are associated with altered vasomotion and signal
conduction along arterioles has led to propose that Cx40
contributes to control blood pressure by mediating the
adaptive changes of the vascular walls, that are induced by
increased pressure and mechanical stress.15–17 However, since
connexins control secretion of various hormones,3,18 and
since the arterial expression of Cx40 is increased in rodents
featuring a renin-dependent hypertension,8,13 we postulated
that loss of Cx40 could also alter the coordinated functioning
of the RSC, hence accounting for increased blood pressure.
Here, we report on the direct testing of this possibility in
mice lacking Cx40 (Cx40/),19,20 and demonstrate that the
hypertension of these mice is mostly due to an altered
production of renin. Thus, these mice represent a valuable
genetic model of renin-dependent increase in blood pressure,
the most common situation in human hypertension.
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RESULTS
The RSC express Cx40, and are altered after loss of this
connexin
In agreement with previous reports,8–13 in situ hybridization
and immunofluorescence showed the expression of Cx40 in
the endothelial cells of the afferent arterioles of wild-type
mice (WT), as well as in RSC that formed the media of the
juxtaglomerular portion of this vessel (Figure 1a and b). No
Cx40 was found in the corresponding regions of homozygous
Cx40/ mice (data not shown).
When compared to the RSC of WT, which expressed
Cx40, the RSC of Cx40/ littermates (Figure 1c), which
lacked Cx40, were more numerous per glomerule (Figure
1d), featured a smaller cytoplasmic volume (Figure 1e) and
decreased (Po0.003) numbers of secretory granules (Figure
1h). Furthermore, whereas in control cells, most of the renin-
containing granules had an irregular outline (Figure 1f), in
cells lacking Cx40, most of these granules were round (Figure
1g and i). Thus, loss of Cx40 alters the cellular composition
of the afferent arteriole as well as the intracellular storage
of renin.
Cx40/ mice are hypertensive due to activation of the
renin–angiotensin system
WT (n¼ 9) and Cx40þ / mice (n¼ 8), which expressed
Cx40, were normotensive (Figure 2a). In contrast, Cx40/
littermates (n¼ 10) featured a 40% increase (Po0.001) in
blood pressure (Figure 2a). This hypertension was associated
with a large increase (Po0.001) in the levels of circulating
renin (Figure 2b). Since no significant difference was
observed between the first two sets of mice, only the data
for the WT controls are shown hereafter.
Treatment with candesartan, an antagonist of the
angiotensin II receptor AT1, or ramipril, an inhibitor of the
angiotensin II converting enzyme (Table 1), reduced the
blood pressure of Cx40/ mice to the levels observed in
control littermates (Figure 3a), in spite of a persistent
elevation of plasma renin (Figure 3b). In contrast, plasma
renin and the expression of renin mRNA in kidneys were
increased in control mice after both treatments (Figure 3b
and c). Thus, the hypertension of Cx40/ mice is due to an
activation of the renin–angiotensin system (RAS), which
results in elevated levels of circulating renin, and that cannot
be properly regulated.
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Figure 1 | Loss of Cx40 alters the organization of the RSC. (a) In control mice, in situ hybridization shows that Cx40 mRNA is expressed along
the endothelial cell (e) that line the lumen of the afferent arteriole (aa), as well as between the RSC (rc) that form the media of the
juxtaglomerular (gl) portion of this vessel. (b) Immunocytochemistry shows a similar localization of the cognate protein. Bar¼ 20mm. (c)
Immunofluorescence reveals the alignment of RSC in three afferent arterioles of a Cx40/ mouse. (d and e) Mice lacking Cx40 had more
renin-containing cells per glomerule than WT controls. (f–i) When compared to controls (f), the RSC of Cx40/ mice (g) were smaller (e) and
contained fewer (h), and more round secretory granules (i). Data are mean7s.e.m. values. ***Po0.001 Cx40/ (solid bars) vs WT values (open
bars). Bar¼ 30mm in (c) and 2 mm in (f) and (g).
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Figure 2 | Cx40/ mice are hypertensive due to increased
levels of circulating renin. (a) Mean blood pressure was higher in
Cx40/ mice (solid bar) than in heterozygous (þ /; shaded bar)
and WT littermates (open bar). (b) Plasma renin activity (PRA) was
markedly increased in the hypertensive Cx40/ mice. Values are
mean7s.e.m. ***Po0.001 Cx40/ vs WT levels.
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In control mice, increased release of renin leads to
enhanced generation of angiotensin II which, in turn,
decreases the expression of the AT1A receptor subtype, that
ultimately controls the RAS.21,22 The expression of this
receptor was significantly lower in Cx40/ mice (n¼ 10)
than in WT littermates (n¼ 9) (Figure 3d), in agreement
Table 1 | Characteristics of the mice treated with inhibitors of the renin–angiotensin system
Group Treatment n Body weight (g) Heart rate (beats/min) LKi (mg/g) RKi (mg/g) Cwi (mg/g)
WT Untreated 9 28.471.7 657714 6.670.4 6.870.4 6.470.3
Candesartan 10 30.171.0 628731 6.970.4 6.870.4 6.170.2
Ramipril 12 26.570.9 634757 6.870.3 6.870.3 5.370.3*
Cx40/ Untreated 10 25.971.0 648722 6.570.2 6.570.2 8.670.7111
Candesartan 12 31.672.5 610737 6.770.3 6.570.3 7.670.6*11
Ramipril 15 27.571.2 68278 7.270.2 7.370.2 7.170.3*11
Cwi, cardiac weight index; LKi, left kidney index (ratio between the left kidney weight and body weight); n, number of mice; RKi, right kidney index.
Values are expressed as mean7s.e.m. *Po0.05 vs untreated mice; 11Po0.01 vs WT mice; 111Po0.001 vs WT mice.
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Figure 3 | High blood pressure and renin levels of Cx40/ mice are caused by an activation of the RAS. (a) Inhibitors of the RAS lowered
blood pressure of Cx40/ mice, but did not affect that of WT controls. (b) Circulating renin was not significantly affected by these treatments
in Cx40/ mice, but was increased in WT controls (WT). (c) Basal expression of renin mRNA was higher in Cx40/ than in WT mice.
Candesartan and ramipril significantly increased the expression of renin in WT animals. (d) Expression of the angiotensin 1 receptor subtype
(AT1A) mRNA was lower in Cx40/ than in WT mice. After induction of hypertension in the 2K1C model, the AT1A levels of WT mice decreased
to the values observed in Cx40/ mice. Values are mean7s.e.m. **Po0.01, ***Po0.001 Cx40/ (solid bars) vs WT levels (open bars).
yPo0.05 vs levels in untreated Cx40/ mice.
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with the much higher levels of circulating renin of the former
mice. The WT levels of AT1A decreased up to the values
observed in Cx40/ animals when WT mice were
submitted to an experimental procedure (2K1C) that causes
hypertension by elevating the circulating levels of renin.
Under the same conditions, the levels of AT1A did not change
in Cx40/ mice (Figure 3d).
The regulation of renin production and secretion is altered in
Cx40/ mice
To identify the underlying mechanism, we first investigated
the effect of diets known to increase (0.03% NaCl) or
decrease (4% NaCl) plasma renin in control mice,
under conditions of constant blood pressure (Figure 4a
and b). Three weeks after exposure to these diet, the
blood pressure of 9 (low-salt diet) to 11 (high-salt diet)
Cx40/ mice was also unchanged and remained
significantly higher than that of WT (Figure 4a). The
circulating levels of renin of Cx40/ mice also remained
markedly elevated compared to physiological levels, and did
not show the changes observed in WT controls. Thus,
whereas these levels were slightly reduced (about half the
control change) after the low-salt diet, they did not increase,
as anticipated by the physiology, after the high salt intake
(Figure 4b). These differences were seen in spite of a similar
regulation of the kidney expression of the renin transcript in
the Cx40/ and the WT mice, during both the low and
high-salt diets (Figure 4c). Thus, loss of Cx40 did affect
selective aspects of the regulation of renin secretion
dependent on the macula densa.
To evaluate how this dysregulation affected the RSC,
WT and Cx40/ mice were submitted to a surgical
2K1C procedure.10,23 The left, hypoperfused kidney
of all 2K1C animals weighed less than that of the sham-
operated mice, whereas the contralateral kidney was sig-
nificantly larger than that of these controls (Table 2).
Also, the heart of hypertensive Cx40/ mice was hyper-
trophied compared to that of WT controls, as indicated
by a 45% increase in cardiac weight index (Table 2).
Four weeks after clipping one renal artery, we observed an
increase in the blood pressure of WT mice (Figure 5a), due
to elevated (Po0.01) levels of circulating renin (Figure 5b),
as a result of a larger production of the enzyme in
the hypoperfused left kidney (Figure 5c and d). When
submitted to the same protocol, Cx40/ mice retained
unchanged their high blood pressure (Figure 5a)
and circulating levels of renin (Figure 5b), in spite of
increased renin expression within the clipped kidney (Figure
5c and d). However, this change was only half that observed
in WT mice, indicating that the regulation of renin secretion
under conditions of altered kidney perfusion was altered
in Cx40/ mice. Consistent with this finding, in situ
hybridization demonstrated that the levels of renin
mRNA were also significantly less reduced in the unclipped
kidney of Cx40/ mice than in that of WT littermates
(Figure 5d).
Loss of Cx40 is not compensated by other connexins in the
RSC
In the 2K1C model, the levels of Cx40 mRNA were found
increased in the hypoperfused kidney of WT mice and
reduced in the contralateral kidney, in agreement with the
differential regulation of renin expression in the two organs
(Figure 6a). Hypertension, was also associated with increased
expression of Cx43 mRNA in both WT and Cx40/ mice
kidneys (Figure 6a), in keeping with the previously reported
changes of this connexin in the vascular wall of hypertensive
animals.8,10,13 The renal mRNA levels of Cx37, another
connexin of the vasculature which is found in the JGA,9
were not modified by the 2K1C procedure in WT controls
(Figure 6a). In contrast, these levels were elevated in the
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Figure 4 | The regulation of renin secretion by salt is altered in
Cx40/ mice. (a) Mean blood pressure of WT (WT) and Cx40/
mice was not altered after feeding a normal (NS), a low (LS), or a high-
salt diet (HS). (b) Under the latter diet, the circulating levels of renin
decreased in both WT and Cx40/ mice. In contrast, a low salt diet
increased renin secretion in WT but not Cx40/ mice. (c) Northern
blots showed that the low and the high-salt diets had opposite
effects on the expression of the renin gene. Data are mean7s.e.m.
values. *Po0.05, **Po0.01, ***Po0.001 vs the NS value of WT mice
(open bars); yPo0.05 vs. NS values of Cx40/ mice (solid bars).
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hypertensive, sham-operated Cx40/ mice, and in the
hypoperfused left kidney of the Cx40/ mice which were
submitted to the 2K1C procedure (Figure 6a).
To assess whether these renal changes in the mRNA levels
of Cx43 and Cx37 provided a compensation for the loss of
Cx40 in RSC, we immunostained kidney sections with
specific antibodies to these two connexins. In agreement with
previous reports,9,10 we identified Cx43 and Cx37 in the
interlobular vessels of WT controls, as well as in the wall of
their afferent arterioles, and glomerular vessels (Figure 6b
and c). In contrast, the RSC of WT mice were immuno-
stained for Cx37 (Figure 6b), but not Cx43 (Figure 6c). In
Table 2 | Characteristics of the 2K1C and sham-operated mice
Group Treatment n Body weight (g) Heart rate (beats/min) LKi (mg/g) RKi (mg/g) Cwi (mg/g)
WT Sham 9 30.570.6 654718 7.370.2 7.370.2 6.570.3
2K1C 9 28.870.8 641724 6.370.2* 8.570.3** 7.870.3*
Cx40/ Sham 11 26.371.6 655718 7.370.4 7.270.3 9.671.211
2K1C 11 28.270.6 669713 5.970.2** 8.470.5** 9.070.611
Cwi, cardiac weight index; LKi, left kidney index; n, number of mice; RKi, right kidney index.
Values are expressed as mean7s.e.m. *Po0.05, **Po0.01 vs 2K1C sham-operated animals; 11Po0.01 vs WT animals.
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Cx40/ mice, a similar distribution was observed for both
Cx37 and Cx43. However, Cx37 appeared reduced in vessels
and RSC (Figure 6b), whereas Cx43 appeared increased
(Figure 6c) in the intimal endothelium and in smooth muscle
cells of the intima and media of large interlobular vessels,
respectively. As in controls, RSC of Cx40/ mice expressed
some Cx37 (Figure 6b) but no Cx43 (Figure 6c). Thus, loss of
Cx40 in RSC is not compensated by an obvious change in the
expression of other connexin proteins, which are expressed in
renal vessels and JGA.
DISCUSSION
The gap junction protein Cx40 has been implicated
in the function of the vascular system, notably because
knockout mice lacking this connexin are hypertensive.
Previous studies have concluded that this hypertension
was mostly due to an abnormal adaptation of the
arterial walls to altered hemodynamic conditions,15–17
implying that Cx40 contributes to the detection
and propagation of the blood-borne signals that are elicited
by increased blood pressure. Here, we show that the
hypertension of Cx40 mice mostly results from alterations
in the number and function of the RSC, and the ensuing
activation of the RAS. We further document that, in
the absence of Cx40, the regulation of this system is altered
both under a low-salt regimen and under conditions of
changed renal blood flow, two situations that are
sensed by different cell types of the JGA.1,2 The data show
that connexins play a central role in the signaling from these
cells, that converge on the myo-epithelial cells of the
juxtaglomerular portion of the afferent arterioles, which
secrete renin.
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These data have two implications. First, they extend to the
RSC, the increasing evidence pointing to connexin signaling
as a major, obligatory player in the control of secretory
systems.3,18 Our data document for the first time that loss of
Cx40 increases the number of RSC, the renal production of
the hormone and its release, indicating that the signaling
dependent on this protein natively downregulates the
function of RSC.
Second, our data show that Cx40 plays a central role in the
regulatory function of the JGA. Thus, loss of this connexin
markedly activates the RAS, altering its normal regulation of
blood pressure, and resulting in hypertension. In view of its
distribution in the membrane of both endothelial cells and
RSC of the afferent arteriole, and its mechano-sensitive
characteristics,24 Cx40 is ideally located to detect blood-
borne signals and to propagate them across the vascular and
the RSC of the JGA, thus permitting the integration of the
mechanical, hormonal, and ionic inputs that control blood
pressure.2,25 By comparing WT and Cx40/ mice in a
renin-dependent (2K1C) model of hypertension our experi-
ments show for the first time that the hypertension of
Cx40/ animals is essentially due to an excessive secretion
of renin, due to increased numbers of RSC, which feature
alterations of their enzyme-containing granules.
Most probably, the signaling mechanism of Cx40 is
integrated with that of both Cx43 and Cx37, two other
connexins that are also expressed within the JGA,8,10 and that
are affected by hypertension.8,10,13,26 With regard to Cx43, we
have recently provided evidence that replacement of this
protein by the Cx32 isoform, which cannot form channels
with Cx40,27 downregulates the secretion of RSC, protecting
transgenic mice against the hypertension which is expected in
a model of renovascular hypertension.10 Cx43 is not detected
in the RSC of WT animals, but is expressed by rare
endothelial cells of arteries, as well as by most smooth
muscle cells of these vessels,13 including the afferent arteriole.
Consistent with previous reports of elevated vascular levels of
Cx43 in different models of experimental hyperten-
sion,8,10,13,26 we show here that the renal levels of Cx43 were
higher in the hypertensive Cx40/ mice than in the
cognate, normotensive controls. We further show that, when
the latter animals were made hypertensive by the 2K1C
procedure, the levels of Cx43 expression rose in the kidneys
of controls, up to the levels observed in the Cx40/ mice
that featured a similar degree of hypertension, due to
excessive renin secretion.
We have not observed an induction of Cx43 in the RSC of
the Cx40/ animals. Therefore, the contribution of this
connexin to the dysregulation of renin secretion may imply
the mediation of an extracellular signal initiated in the
endothelial and/or smooth muscle cells of the afferent
arteriole, since Cx40 and Cx43 appear unable to form
functional heterotypic gap junction channels.28 The close
apposition of RSC, endothelial, and smooth muscle cells of
the JGA provides an ideal setting for paracrine effects within
the afferent arteriole.8 An analogous, connexion-dependent
paracrine mechanism has been recently postulated in the stria
vascularis epithelium of the inner ear.29 With regard to Cx37,
its coexpression with Cx40 in the RSC9 raises the question of
which of the two connexin isoforms is actually responsible
for the increased renin secretion of Cx40/ mice. Several
observations indicate that Cx40 largely predominates in this
role. Thus, Cx37/ mice, which still express Cx40, are
normotensive,30 and no obvious change was observed in the
expression of Cx37 in hypertensive 2K1C WT mice, which
feature a striking upregulation of renin expression. Still, and
in agreement with a previous suggestion in the vascular
compartment,30 we observed that the levels of the Cx37
protein were decreased in the kidneys of the Cx40/ mice,
indicating that the expression of Cx40 and Cx37 are
somehow interdependent. Our findings are consistent with
a model in which proper renin secretion depends both on the
homotypic signaling ensured by Cx40 between the RSC
themselves, and on a heterotypic signaling, mediated by
Cx40, and possibly Cx37, between RSC and the endothelial
and/or smooth muscle cells of the afferent arteriole.
Full validation of these tentative conclusions requires that
the paracrine signal(s) and mechanism dependent on Cx43
be identified, and that the incidence and extent of the
homotypic RSC coupling dependent on Cx40 be compared,
within the intact kidney, to those of the heterotypic
communication between RSC and vascular cells mediated
by Cx37–Cx40 channels. Both are formidable tasks in view of
the small number and dispersion of RSC within the kidney
cortex, and the tight intermingling of the different cell types
that collectively form the JGA. Therefore, at least two
complementary, if not alternative, possibilities should be
considered at this stage. The first possibility finds its basis on
recent studies that have documented that specific connexins
selectively affect the expression of a variety of genes, by a
mechanism that remains to be elucidated and that may be
independent of the establishment of cell-to-cell communica-
tion.29,31,32 Thus, large-scale transcriptome analysis of
different cell and animal models have shown that Cx43 and
Cx32 regulate an array of genes involved in the control of cell
growth,31,32 whereas Cx30 appears to preferentially control
genes implicated in the metabolism of homocysteine.29
Strikingly, the tissue accumulation of this amino acid, which
is seen in the absence of Cx30, triggers a local, presumably
paracrine mechanism which eventually results in the altered
function of endothelial cells that do not express this connexin
isoform.29 The second more intriguing possibility is that, as
in any other study involving knockout mice,33 the physio-
logical relevance of the effects we observed may be over-
estimated, because of the compounding effect of
experimentally induced alterations, that, in our case, could
be largely due to over time compensation of the missing Cx40
by other connexin isoforms or some connexin-dependent
gene. However, the finding that both the pharmacological
(RAS inhibitors, salt load, or depletion) and surgical
interventions (2K1C) elicited similar, and anticipated, blood
pressure and renin changes in WT and Cx40þ / mice,
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whereas selective alterations of these physiological changes
were solely observed in Cx40/ mice, plaids against this
possibility. Furthermore, while we have documented changes
in the transcripts of other connexin isoforms in the kidney of
the hypertensive animals, we have also shown that the
cognate proteins were either not ectopically expressed (Cx43)
or at best somewhat decreased (Cx37) in RSC. The latter
change is unlikely to have cause the pressure perturbations
we observed, inasmuch as Cx37/ mice, which still express
Cx40, are normotensive.30 Still, what is the actual physiolo-
gical role of Cx40 in the kidney of living WT mice remains to
be validated in other models, including cell- and time-
specific knockout and siRNA interference studies. By acutely
decreasing the expression of Cx40 in selected cell types, these
approaches should avoid the conundrum of compensation
and mechanistic adaptations that probably occur over time in
any knockout animal.
Awaiting the completion of such studies, our findings
open new paradigms to envision the still obscure pathogen-
esis of hypertension. Since polymorphisms of the Cx40 gene
have been recently associated with human hypertension,34,35
our data call for an evaluation of renin function in the
affected patients. They also point to the Cx40/ mice as a
pertinent genetic model to unravel further the molecular
mechanisms of renin-dependent hypertension, a most
common situation in the human clinic.
MATERIALS AND METHODS
Knockout mice
The generation of Cx40/ mice and their genotypic characteriza-
tion have been described.19 Breeding pairs (kindly provided by
Dr K Willecke) were crossed with control C57BL6 partners.
Identification of the WT, heterozygous (þ /), and homozygous
Cx40/ mice was performed by PCR of genomic DNA using the
following primers: for the Cx40 WT allele (314 bp), 50-GGGAGATG
AGCAGGCCGACTTCCGGTGCG-30 (sense) and 50-GTAGGGTGC
CCTGGAGGACAATCTTCCC-30 (antisense); for the Cx40 recom-
binant allele (494 bp), 50-GGATCGGCCATTGAACAAGATGGAT
TGCAC-30 (sense) and 50-CTGATGCTCTTCGTCCAGATCATCCTG
ATCG-30 (antisense). Three 4-month-old animals, from litters
obtained after at least 10 backcrosses into the C57/BL6 background,
were used in all the experiments.
Morphometric and ultrastructural analysis
To analyze the number and distribution of RSC, kidneys were fixed
in 4% paraformaldehyde in 0.1 M phosphate buffer, embedded in
paraffin, and serially sectioned at 5 mm thickness. Sections were
immunostained using a rabbit polyclonal antibody against renin
(2D12, courtesy of Professor P Corvol, Paris), diluted 1:200, and
evaluated morphometrically as per standard methods.36
Animal experiments
Mouse care, surgery, and euthanasia procedures were approved by
our Institutional Committee for Animal Experiments and the
Veterinary Office (Lausanne, Switzerland).
Modulating RAS. Blockade of the RAS was performed by
adding to the drinking water either 3 mg/kg day the AT1-receptor
antagonist candesartan (Cilexetils, Astra Zeneca, Zoug, Switzer-
land) or 10 mg/kg day the angiotensin-converting enzyme inhibitor
ramipril (Aventis, Geneva, Switzerland) for 3 weeks. To test the
effects of a salt load, another series of mice was fed for 3 weeks with
a diet (Kliba, Gossau, Switzerland) containing either 0.03% (low-salt
group), 4% (high-salt group), or 0.3% NaCl (control group).
All mice had free access to tap water.
Inducing a renin-dependent hypertension. For the two-
kidney, one clip model (2K1C), the left renal artery was clipped
with a 0.12 mm internal diameter U-shaped silver clip, as described
previously.10,23
Measurement of blood pressure. One day before killing, the
right carotid artery was penetrated with a catheter connected to a
pressure transducer and a computerized data acquisition system,
that allowed for recording heart rate and both diastolic and systolic
intra-arterial pressure in conscious mice every 20 s.10 Data are
shown as the mean (MBP) of the diastolic and systolic values. After
a 30-min recording period, 300 ml blood was collected in
ethylenediaminetetraacetic acid-coated tubes and centrifuged at
41C. Plasma was stored at 701C until use.
Measurements of plasma renin
Plasma renin activity was measured by a microassay based on
angiotensin I (Ang I) trapping by an antibody.10 Controls showed
that endogenous angiotensinogen was not a limiting factor for the
measurement of the high levels of renin found in the hypertensive
mice (data not shown).
RNA analysis
RNA isolation and Northern blot analysis were performed as
described10 using cDNA probes specific for either renin10 or a 1.1 kb
(HindIII–EcoRI) fragment of GAPDH cDNA.8 Quantitative real-
time PCR was performed as reported10,37 using the following
primers: for renin (158 bp), -50-TCTCTGGGCACTCTTGTTGC
TCTG-30- (sense) and -50-ATACGTCCCATTCAGCACTGAGCC-30-
(antisense); for GAPDH (334 bp), -50-gactccacgacatactcagc-30-
(sense) and -50-gtcggtgtgaacggatttgg-30- (antisense); for AT1a
(110 bp), 50-GTCGCACTCAAGCCTGTCTA-30 (sense); for Cx40
(310 bp), -50-TTTGGCAAGTCACGGCAGGG-30 (sense) and 50-TG
TCACTATGGTAGCCCTGAG-30 (antisense);38 for Cx37 (144 bp),
50-GGGAGATAAAGGCACGAAGG-30 (sense) and 50-ATGAGAGC
CCGTTGTAGGTG-30 (antisense); for Cx43 (255 bp), 50-GATTGAA
GAACACGGCAAGG-30 (sense) and 50-AGAGCGAGAGACACCA
AGGA-30 (antisense). Analysis of data was performed using the 3.5
version of the Light Cycler software (Roche Diagnostics, Zong,
Switzerland, GmbH, Germany). For the in situ hybridization of the
renin and Cx40 transcripts, kidneys sections were hybridized as
previously described.8,10
Analysis of connexins
Immunodetection of connexins was performed as previously
reported.10 Cryostat sections of kidneys (5mm thickness) were
permeabilized 10 min in cold (201C) acetone, and incubated 2 h at
room temperature, using the following rabbit polyclonal antibodies:
for Cx40, the antibody described by Haefliger et al.,8 diluted 1:250;
for Cx37, the antibodies described by Haefliger et al.39 and Delorme
et al.,40 diluted 1:100; for Cx43, the antibodies 71-0700 (Zymed,
Basel, Switzerland), diluted 1:100, C6219 (Sigma) diluted 1:200, or
that described,41 diluted 1:50. At the end of the immunolabeling, the
sections were counterstained 3 min in 0.03% Evans blue (in
phosphate-buffered saline), which gives the tissues a red background
Kidney International (2007) 72, 814–822 821
N Krattinger et al.: Renin secretion and Cx40 o r i g i n a l a r t i c l e
staining that enhances the visualization of the fluorescein isothio-
cynate immunosignals.36
Statistical analysis
Data were expressed as mean7s.e.m. Differences between means
were assessed using Student’s t-test. Statistical significance was
defined at a value of Po0.05 (* or, 1 or #, or y), Po0.01 (**, or 11, or
##, or yy), Po0.001 (***, or 111, or ###, or yyy).
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NOTE ADDED IN PROOF
After the submission of our study, the following papers
independently confirmed that the hypertension of Cx40/ mice
is largely due to altered function (Circ Res 2007; 100: 556) and
organization of renin-producing cells (J Am Soc Nephrol 2007; 18:
1103).
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